- Home
- EPWK vs CODX Comparison
EPWK vs CODX Comparison
Compare EPWK & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPWK
- CODX
- Stock Information
- Founded
- EPWK 2011
- CODX 2013
- Country
- EPWK China
- CODX United States
- Employees
- EPWK N/A
- CODX N/A
- Industry
- EPWK
- CODX Medical/Dental Instruments
- Sector
- EPWK
- CODX Health Care
- Exchange
- EPWK Nasdaq
- CODX Nasdaq
- Market Cap
- EPWK 9.5M
- CODX 9.8M
- IPO Year
- EPWK 2025
- CODX 2017
- Fundamental
- Price
- EPWK $0.56
- CODX $0.34
- Analyst Decision
- EPWK
- CODX Buy
- Analyst Count
- EPWK 0
- CODX 2
- Target Price
- EPWK N/A
- CODX $5.50
- AVG Volume (30 Days)
- EPWK 2.0M
- CODX 5.2M
- Earning Date
- EPWK 11-11-2025
- CODX 11-06-2025
- Dividend Yield
- EPWK N/A
- CODX N/A
- EPS Growth
- EPWK N/A
- CODX N/A
- EPS
- EPWK N/A
- CODX N/A
- Revenue
- EPWK $20,164,008.00
- CODX $1,003,653.00
- Revenue This Year
- EPWK N/A
- CODX N/A
- Revenue Next Year
- EPWK N/A
- CODX $31.58
- P/E Ratio
- EPWK N/A
- CODX N/A
- Revenue Growth
- EPWK 10.25
- CODX N/A
- 52 Week Low
- EPWK $0.29
- CODX $0.23
- 52 Week High
- EPWK $26.00
- CODX $1.40
- Technical
- Relative Strength Index (RSI)
- EPWK N/A
- CODX 62.83
- Support Level
- EPWK N/A
- CODX $0.30
- Resistance Level
- EPWK N/A
- CODX $0.33
- Average True Range (ATR)
- EPWK 0.00
- CODX 0.03
- MACD
- EPWK 0.00
- CODX 0.00
- Stochastic Oscillator
- EPWK 0.00
- CODX 60.32
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.